RGEN · Repligen Corp · Webcasts, Transcripts & Audio
$167.79
+1.27 (+0.76%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$10.73B
Shares
63.92M
Volume · Nov 13
510.17K
Avg daily vol (3M)
1.19M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Repligen Corp Webcasts
Earnings calls, investor updates, investor days and conferences for Repligen Corp (RGEN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-18
Repligen Corp (RGEN) November 18, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-10-27
Repligen Corp (RGEN) Q3 2026 Earnings Call Transcript
Confident tone
Diversified product franchise performance
BioLife acquisition and integration
Filtration headwinds and deferred demand
Revenue
$209.31M
▲ 10.9% YoY Diluted EPS
$-0.68
▼ 361.5% YoY Gross margin
53.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-09
Repligen Corp (RGEN) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-28
Repligen Corp (RGEN) Q2 2026 Earnings Call Transcript
Confident tone
Protein franchise growth
BioLife acquisition (cell therapy)
Analytics franchise momentum
Revenue
$204.13M
▲ 11.9% YoY Diluted EPS
$0.09
▼ 65.4% YoY Gross margin
53.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-07-22
Repligen Corp (RGEN) July 22, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
Repligen Corp (RGEN) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-05-12
Repligen Corp (RGEN) May 12, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-05
Repligen Corp (RGEN) Q1 2026 Earnings Call Transcript
Confident tone
Analytics Franchise Growth
Margin Expansion / Transformation Office
Polymem Divestiture
Revenue
$194.25M
▲ 14.8% YoY Diluted EPS
$0.15
▲ 50% YoY Gross margin
55.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-10
Repligen Corp (RGEN) March 10, 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-24
Repligen Corp (RGEN) Q4 2025 Earnings Call Transcript
Confident tone
Capital equipment and CapEx demand
Services growth opportunity
End markets and geographies
Revenue
$197.91M*
▲ 18.1% YoY Gross margin
51.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-28
Repligen Corp (RGEN) Q3 2025 Earnings Call Transcript
Confident tone
Franchise Performance
End Market and Geographic Strength
New Modalities
Revenue
$188.81M
▲ 21.9% YoY Diluted EPS
$0.26
Gross margin
53.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-29
Repligen Corp (RGEN) Q2 2025 Earnings Call Transcript
Confident tone
New Modalities / Gene Therapy Headwind
China and APAC Regional Outlook
Margin and Operating Leverage
Revenue
$182.37M
▲ 14.8% YoY Diluted EPS
$0.26
▲ 160% YoY Gross margin
51.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-29
Repligen Corp (RGEN) Q1 2025 Earnings Call Transcript
Confident tone
Orders momentum
Strategic initiatives and M&A
Customer diversification and geographic exposure
Revenue
$169.17M
▲ 10.4% YoY Diluted EPS
$0.10
▲ 66.7% YoY Gross margin
54.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-20
Repligen Corp (RGEN) Q4 2024 Earnings Call Transcript
Confident tone
Revenue and orders momentum
CDMO and equipment recovery
Hardware platform wins
Revenue
$167.55M*
▲ 0.6% YoY Gross margin
23.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Repligen Corp (RGEN) Q3 2024 Earnings Call Transcript
Confident tone
Orders and backlog momentum
Regional performance and China headwind
CDMO recovery
Revenue
$154.87M
▲ 9.7% YoY Diluted EPS
$-0.01
▼ 103.3% YoY Gross margin
50.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-30
Repligen Corp (RGEN) Q2 2024 Earnings Call Transcript
Positive tone
2024 guidance and FX
CDMO order recovery
China demand weakness
Revenue
$158.84M
▼ 0.2% YoY Diluted EPS
$0.10
▼ 71.4% YoY Gross margin
51.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
Repligen Corp (RGEN) Q1 2024 Earnings Call Transcript
Positive tone
Order trends and book-to-bill
Filtration franchise strength
Proteins / affinity ligand headwind
Revenue
$153.18M
▼ 7.4% YoY Diluted EPS
$0.06
▼ 77.8% YoY Gross margin
50.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-21
Repligen Corp (RGEN) Q4 2023 Earnings Call Transcript
Positive tone
M&A / Metenova Integration
Market Recovery Indicators
China Deterioration
Revenue
$166.62M*
▼ 10.8% YoY Gross margin
47.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-31
Repligen Corp (RGEN) Q3 2023 Earnings Call Transcript
Revenue
$141.19M
▼ 29.7% YoY Diluted EPS
$0.30
▼ 57.7% YoY Gross margin
25.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
Repligen Corp (RGEN) Q2 2023 Earnings Call Transcript
Revenue
$159.17M
▼ 23.3% YoY Diluted EPS
$0.35
▼ 60.2% YoY Gross margin
50.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
Repligen Corp (RGEN) Q1 2023 Earnings Call Transcript
Revenue
$165.38M
▼ 19.9% YoY Diluted EPS
$0.27
▼ 66.7% YoY Gross margin
50.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-22
Repligen Corp (RGEN) Q4 2022 Earnings Call Transcript
Revenue
$186.76M*
▲ 0.1% YoY Gross margin
51.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-01
Repligen Corp (RGEN) Q3 2022 Earnings Call Transcript
Revenue
$200.74M
▲ 12.6% YoY Diluted EPS
$0.71
▲ 22.4% YoY Gross margin
56.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Repligen Corp (RGEN) Q2 2022 Earnings Call Transcript
Revenue
$207.63M
▲ 27.4% YoY Diluted EPS
$0.88
▲ 37.5% YoY Gross margin
58.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-27
Repligen Corp (RGEN) Q1 2022 Earnings Call Transcript
Revenue
$206.40M
▲ 44.5% YoY Diluted EPS
$0.81
▲ 55.8% YoY Gross margin
60.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-17
Repligen Corp (RGEN) Q4 2021 Earnings Call Transcript
Revenue
$186.52M*
▲ 71.7% YoY Gross margin
56.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-28
Repligen Corp (RGEN) Q3 2021 Earnings Call Transcript
Revenue
$178.22M
▲ 89.5% YoY Diluted EPS
$0.58
▲ 114.8% YoY Gross margin
57.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-27
Repligen Corp (RGEN) Q2 2021 Earnings Call Transcript
Revenue
$162.96M
▲ 86.3% YoY Diluted EPS
$0.64
▲ 113.3% YoY Gross margin
62.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Repligen Corp (RGEN) Q1 2021 Earnings Call Transcript
Revenue
$142.84M
▲ 87.7% YoY Diluted EPS
$0.52
▲ 188.9% YoY Gross margin
58.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Repligen Corp (RGEN) Q4 2020 Earnings Call Transcript
Revenue
$108.65M
▲ 56.4% YoY Diluted EPS
$0.36
▲ 414.3% YoY Gross margin
55.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Repligen Corp (RGEN) Q3 2020 Earnings Call Transcript
Revenue
$94.06M
▲ 35.4% YoY Diluted EPS
$0.27
▲ 800% YoY Gross margin
57.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-30
Repligen Corp (RGEN) Q2 2020 Earnings Call Transcript
Revenue
$87.46M
▲ 23.7% YoY Diluted EPS
$0.30
▲ 76.5% YoY Gross margin
57.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Repligen Corp (RGEN) Q1 2020 Earnings Call Transcript
Revenue
$76.09M
▲ 25.5% YoY Diluted EPS
$0.18
▲ 5.9% YoY Gross margin
58.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-20
Repligen Corp (RGEN) Q4 2019 Earnings Call
Revenue
$69.47M
▲ 33.8% YoY Diluted EPS
$0.07
▼ 41.7% YoY Gross margin
56.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–34 of 34 webcasts
Key facts
CIK
730272
CUSIP
759916109
13F (30d)
399 filings
365 filers
Visit website
Investor relations